Niraparib Tosylate Monohydrate

US Brand Name(s) of Niraparib Tosylate Monohydrate: Zejula

Use in Cancer Treatment

Niraparib tosylate monohydrate is to treat the following conditions:

  • Ovarian epithelial cancer, fallopian tube cancer, or primary peritoneal cancer are all examples of ovarian cancer. It’s prescribed for individuals with advanced cancer who have had a full or partial response to first-line platinum chemotherapy.
  • Adults with recurrent illness who have had a complete or partial response to platinum chemotherapy as maintenance treatment.
  • Adults with advanced cancer who have had at least three chemotherapy regimens and whose illness either has specific mutations in the BRCA1 or BRCA2 genes; or has certain mutations in the BRCA1 or BRCA2 gene.
  • Has genomic instability that has worsened following a platinum chemotherapeutic response.
  • Niraparib tosylate monohydrate is a kind of niraparib tosylate.

Detailed scientific definition – Definition from the NCI Drug Dictionary 

Niraparib Tosylate Monohydrate – MedlinePlus Information

A summary of key facts regarding this medication in layman’s terms, which may contain the following:

  • Cautions about this medicine
  • What is the use and how?
  • Whom should you consult before taking it?
  • What you should know about it before using it?
  • Other drugs that might interact with it
  • Possible negative effects

Drugs are frequently under research to see whether they can assist treat or prevent conditions other than those already prevalent. This patient information leaflet covers uses which have been under authorization. Much of the material, though, might also apply to authorized uses that are being investigated.